Compounds > perflutren
Page last updated: 2024-08-17

perflutren and Cardiac Diseases

perflutren has been researched along with Cardiac Diseases in 6 studies

Research

Studies (6)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (16.67)29.6817
2010's5 (83.33)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Adams, RJ; Chammas, MC; Cosgrove, DO; Darge, K; Feinstein, LM; Feinstein, SB; Fowlkes, B; Goldberg, BA; Grayburn, PA; Greenbaum, L; Main, ML; Mathias, W; Monaghan, M; Moriyasu, F; Nihoyannopoulos, P; Parker, JM; Piscaglia, F; Weller, MW; Wilson, S1
Erlien, D; Gilbertson, DT; Herzog, CA; Kalra, A; Shroff, GR1
Bennett, CE; Michelena, HI; Mulvagh, SL; Schears, GJ; Tweet, MS1
Lerakis, S; Nam, D1
Abdelmalik, R; Choi, JH; Hong, GR; Kim, JK; Kim, U; Lee, SH; Narula, J; Park, JS; Shin, DG; Vannan, MA; Vera, JA1
Abdelmoneim, SS; Bellavia, D; Bernier, M; Chandrasekaran, K; Mankad, SV; Mulvagh, SL; Pellikka, PA; Syed, IS1

Reviews

1 review(s) available for perflutren and Cardiac Diseases

ArticleYear
Safety of ultrasound contrast agents in patients with known or suspected cardiac shunts.
    The American journal of cardiology, 2013, Oct-01, Volume: 112, Issue:7

    Topics: Albumins; Contraindications; Contrast Media; Echocardiography; Fluorocarbons; Heart Diseases; Humans

2013

Other Studies

5 other study(ies) available for perflutren and Cardiac Diseases

ArticleYear
Perflutren-based echocardiographic contrast in patients with right-to-left intracardiac shunts.
    JACC. Cardiovascular imaging, 2014, Volume: 7, Issue:2

    Topics: Albumins; Contrast Media; Coronary Circulation; Echocardiography; Fluorocarbons; Heart Diseases; Hemodynamics; Humans; Patient Selection; Predictive Value of Tests; Retrospective Studies; Risk Assessment; Risk Factors

2014
Safety and Feasibility of Contrast Echocardiography for ECMO Evaluation.
    JACC. Cardiovascular imaging, 2017, Volume: 10, Issue:5

    Topics: Contrast Media; Echocardiography, Transesophageal; Equipment Failure; Extracorporeal Membrane Oxygenation; Feasibility Studies; Fluorocarbons; Heart Diseases; Humans; Microbubbles; Oxygenators, Membrane; Predictive Value of Tests; Retrospective Studies; Treatment Outcome

2017
The use of contrast echo to clear the left atrial appendage.
    Acute cardiac care, 2011, Volume: 13, Issue:2

    Topics: Aspirin; Atrial Appendage; Clopidogrel; Contrast Media; Drug Therapy, Combination; Echocardiography; Echocardiography, Transesophageal; Fluorocarbons; Heart Atria; Heart Diseases; Humans; Male; Middle Aged; Platelet Aggregation Inhibitors; Thrombosis; Ticlopidine

2011
Prognostic value of real time dobutamine stress myocardial contrast echocardiography in patients with chest pain syndrome.
    The international journal of cardiovascular imaging, 2011, Volume: 27 Suppl 1

    Topics: Chest Pain; Contrast Media; Diagnosis, Differential; Disease-Free Survival; Echocardiography, Stress; Emergency Medical Services; Female; Fluorocarbons; Follow-Up Studies; Heart Diseases; Humans; Image Enhancement; Male; Middle Aged; Predictive Value of Tests; Prognosis; Radionuclide Imaging; Retrospective Studies; Syndrome

2011
Myocardial contrast echocardiography in biopsy-proven primary cardiac amyloidosis.
    European journal of echocardiography : the journal of the Working Group on Echocardiography of the European Society of Cardiology, 2008, Volume: 9, Issue:2

    Topics: Amyloidosis; Biopsy; Contrast Media; Echocardiography; Echocardiography, Stress; Fluorocarbons; Gadolinium DTPA; Heart Diseases; Humans; Magnetic Resonance Imaging; Male; Middle Aged; Vasodilator Agents

2008